Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03059316
Other study ID # N532016
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date June 10, 2016
Est. completion date April 21, 2017

Study information

Verified date January 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Controlled hypotension has been used as a mean of reducing intraoperative blood loss and better visualization of the surgical field in nasal surgeries. Perfusion index has been considered a useful tool for monitoring changes in peripheral perfusion using Masimo set and serum lactate for central perfusion. Many medications were used to induce hypotension. In this study we will compare the effects of tridil and labetalol on the perfusion.


Description:

The purpose of this study to detect the degree of hypotension that helps the surgeon and dosen`t impair patient`s perfusion and to compare the hypotensive effects of both tridil and labetalol infusions on the perfusion.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 21, 2017
Est. primary completion date April 10, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- ASA I-II males and females aged 18-45 years who were scheduled for Functional Endoscopic sinus surgery (FESS)

Exclusion Criteria:

- uncontrolled hypertension, cerebrovascular disorders, bleeding and coagulation disorders, coronary artery diseases, renal or hepatic diseases or known hypersensitivity to the drugs used and pregnant.

Study Design


Related Conditions & MeSH terms

  • Controlled Hypotension for Nasal Surgeries
  • Hypotension

Intervention

Combination Product:
Massimo device
Massimo is a newly introduced device which can measure the peripheral organ perfusion and expressed it as perfusion index(PI).
Drug:
Nitroglycerin drug
Nitroglycerin is a drug used as an hypotensive agent through its vasodilation effect on veins
Labetalol
Labetalol is an antagonist of adrenergic receptors (a1, b1, b2) which is used as an hypotensive inducer. This drug targets the beta receptors 5 to 10 times more specific than alpha receptors so that minor tachycardia happens

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary perfusion index perfusion index is an indication of peripheral perfusion 3hrs
Primary serum lactate level lactate level is an indication of central perfusion 3hrs
Secondary surgical feild score isan indication of adequacy of controlled hypotension 3hrs